Update on medical treatment for symptomatic uterine myomas

• Autor(a) principal: Ferreira,Helder
• Data de Publicação: 2022
• Outros Autores: Faustino,Fátima, Águas,Fernanda, Osório,Filipa, Martinho,Margarida, Silva,Daniel P.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200134
• topic: Uterine diseases; Uterine fibroids; Long-term care; Uterine hemorrhages

Abstract The medical treatment of uterine fibroids is a subject of growing interest, often associated to difficult decisions, especially in women who wish to preserve fertility and the uterus. The existing treatments are only used for short or limited periods, due to the evidence paucity on the benefits and risks of long-term use. New molecules are being tested showing improved efficacy in the management of uterine fibroids associated symptoms, especially in abnormal uterine bleeding and good safety profiles. The recent data which supports the new treatment options for symptomatic uterine fibroids, particularly in the control of abnormal uterine bleeding, are reviewed herein.